CDEK
← All organizations

Nippon Shinyaku Co Ltd

For profitContributed to NMEWebsite ↗

Also known as: Funded by Toyo Shinyaku Co Ltd | NIPPON SHINYAKU | Nippon Shinyaku Co., Ltd. | NS Pharma, Inc. | Toyo Shinyaku Co Ltd

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Sep 1, 2002

First marketed drug

Aug 12, 2020

First NDA

Aug 12, 2020

Last known activity

Nov 8, 2023

Timeline

1910s

  1. Jun 1, 1911

    Nippon Shinyaku Co Ltd— Founded

2020s

  1. Aug 12, 2020

    viltolarsen— Marketing Organization

  2. Aug 12, 2020

    viltolarsen— NDA Organization

  3. Aug 12, 2020

    viltolarsen— NDA Secondary Org

Drugs by trial phase (10 distinct, 19 trials)

Phase 4 (3 own, 0 via acquisition)

Phase 2 (4 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (27)

Details

Founded
Kyoto, JP Jun 1, 1911
First NDA
Aug 12, 2020
Last known activity
Nov 8, 2023

Designations held

  • Orphan drug
  • Fast track
  • Priority review
  • Accelerated approval